ClinicalTrials.govpublic full text
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
multiple myeloma, radium-223 dichloride, bortezomib, dexamethasone, early relapsed multiple myeloma, combination therapy multiple myeloma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 873106
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.